11 results on '"Wiskemann, Joachim"'
Search Results
2. Exercise for individuals with bone metastases: A systematic review
- Author
-
Weller, Sarah, Hart, Nicolas H., Bolam, Kate A., Mansfield, Sami, Santa Mina, Daniel, Winters-Stone, Kerri M., Campbell, Anna, Rosenberger, Friederike, Wiskemann, Joachim, Quist, Morten, Cormie, Prue, Goulart, Jennifer, and Campbell, Kristin L.
- Published
- 2021
- Full Text
- View/download PDF
3. Muscle hypertrophy in cancer patients and survivors via strength training. A meta-analysis and meta-regression
- Author
-
Koeppel, Maximilian, Mathis, Katlynn, Schmitz, Kathryn H., and Wiskemann, Joachim
- Published
- 2021
- Full Text
- View/download PDF
4. Exercise and lung cancer surgery: A systematic review of randomized-controlled trials
- Author
-
Himbert, Caroline, Klossner, Nicole, Coletta, Adriana M., Barnes, Christopher A., Wiskemann, Joachim, LaStayo, Paul C., Varghese Jr., Thomas K., and Ulrich, Cornelia M.
- Published
- 2020
- Full Text
- View/download PDF
5. Exercise oncology: It is time to make a change
- Author
-
Avancini, Alice, Belluomini, Lorenzo, Tregnago, Daniela, Trestini, Ilaria, Lanza, Massimo, Milella, Michele, Wiskemann, Joachim, and Pilotto, Sara
- Published
- 2022
- Full Text
- View/download PDF
6. A Systematic Review and Meta-analysis of Physical Exercise Prehabilitation in Major Abdominal Surgery (PROSPERO 2017 CRD42017080366).
- Author
-
Heger, Patrick, Probst, Pascal, Wiskemann, Joachim, Steindorf, Karen, Diener, Markus K., and Mihaljevic, André L.
- Subjects
ABDOMINAL surgery ,EXERCISE ,META-analysis ,SURGICAL complications ,RANDOMIZED controlled trials - Abstract
Background: Physical exercise prehabilitation has been proposed to improve postoperative outcomes in patients undergoing major abdominal surgery. The aim of this systematic review was to investigate the effect of preoperative exercise training compared with standard care on postoperative outcomes in major abdominal surgery.Methods: Randomized controlled trials (RCT) comparing prehabilitation with standard care were identified by a systematic literature search of MEDLINE and CENTRAL. Qualitative and quantitative analyses of perioperative outcome data were conducted. Meta-analyses were performed wherever possible and meaningful.Results: A total of eight trials including 442 patients met the inclusion criteria. These trials investigated the effect of prehabilitation in patient cohorts undergoing major liver, colorectal, gastroesophageal, and general abdominal surgery. Quantitative analyses of all included trials showed a significant reduction in postoperative pulmonary complications (OR 0.37; 0.20 to 0.67; p = 0.001) as well as in postoperative overall morbidity (OR 0.52; 0.30 to 0.88; p = 0.01) in the prehabilitation group compared with standard care. The length of hospital stay showed no significant differences between the groups (MD - 0.58; - 1.28 to 0.13; p = 0.11). Risk of bias and methodological quality varied substantially among the trials, most of which were small single-center studies.Conclusion: Prehabilitation including a physical exercise intervention may lead to a reduction of postoperative pulmonary complications as well as less overall morbidity compared with standard care in patients undergoing major abdominal surgery. Further, well-designed RCT are needed to evaluate these potential positive effects in more detail and to identify suitable target populations.Protocol Registration: PROSPERO 2017 CRD42017080366. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Bone resorption and bone metastasis risk.
- Author
-
Mathis, Katlynn M., Sturgeon, Kathleen M., Winkels, Renate M., Wiskemann, Joachim, De Souza, Mary Jane, and Schmitz, Katherine H.
- Subjects
BONE resorption ,BREAST cancer ,TUMORS ,BONE metastasis ,OSTEOBLASTS ,ANIMALS ,ANTINEOPLASTIC agents ,APOPTOSIS ,BONES ,BONE growth ,BONE tumors ,BREAST tumors ,CELL differentiation ,CONNECTIVE tissue cells ,MACROPHAGES ,MATHEMATICAL models ,METASTASIS ,MICE ,THEORY ,BONE density ,DISEASE complications ,PHARMACODYNAMICS - Abstract
Breast cancer tumors have a tendency to metastasize to the bone. After development of a bone metastasis, the median survival time is 40 months. Currently, little is known about the modifiable risk factors for developing bone metastases in women diagnosed with breast cancer. One possible modifiable risk factor is increased bone resorption. Increased bone resorption is caused by an imbalance between osteoblasts and osteoclasts favoring osteoclast-driven bone resorption. Osteoclast activity results in the release of growth factors from the bony matrix that are requirement for successful breast cancer tumor cell proliferation within the bone. Mice studies have shown that mice that have been genetically engineered to have higher bone mineral density, and thus lower bone resorption, have a decreased incidence of bone metastases. Alternatively, mice genetically engineered to have lower bone mineral density or increased bone resorption have a higher incidence of bone metastases. In human studies, antiosteoporotic drugs have been shown to decrease osteoclast activity and prevent bone metastases. These studies suggest that increased osteoclast activity, which results in low bone mineral density, may be a modifiable risk factor for developing bone metastases in women with breast cancer. Women undergoing chemotherapy for breast cancer develop low bone mineral density in response to the direct effects of chemotherapeutic drugs on bone cells-including osteoclasts, osteoblasts, and osteocytes-and through the decrease in circulating estrogen as a result of chemotherapy-induced ovarian dysfunction. Therefore, it is important for future studies to determine the risk of developing bone metastases associated with increasing bone resorption as measured by low or decreasing bone mineral density in women diagnosed with breast cancer, as well as to determine the best intervention(s) to promote a balance between osteoclasts and osteoblasts to favor osteoblast activity during chemotherapy treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Exercise and chemotherapy-induced amenorrhea.
- Author
-
Mathis, Katlynn M., Sturgeon, Kathleen M., Winkels, Renate M., Wiskemann, Joachim, Williams, Nancy I., and Schmitz, Kathryn
- Subjects
AMENORRHEA ,CANCER chemotherapy ,ENDOTHELIUM diseases ,PROTHROMBIN ,CYCLOPHOSPHAMIDE - Abstract
Chemotherapy-induced amenorrhea (CIA) is the temporary or permanent loss of menses experienced by premenopausal women undergoing chemotherapy treatment for cancer. Two possible mechanisms through which chemotherapy induces CIA have been identified: systemic endothelial dysfunction, resulting in decreased blood flow to the ovaries, and increased oxidative stress within the ovaries, both of which are proposed to lead to apoptosis of follicles. Endothelial dysfunction in ovarian arteries in women undergoing or who have undergone chemotherapy treatment is characterized by prothrombotic changes and thickening of the vascular wall. These changes result in occlusion of the blood vessels. Oxidative stress is increased and antioxidants decreased in the ovaries secondary to chemotherapy drugs, specifically cyclophosphamide. It is hypothesized that low to moderate intensity aerobic exercise during chemotherapy may prevent these changes and lessen the risk for developing CIA in premenopausal women. Low to moderate intensity aerobic exercise has been shown to improve endothelial function and blood flow in patients with cardiovascular disease-a disease state characterized by endothelial dysfunction and for which patients who have undergone chemotherapy are at increased risk. In mice, moderate intensity aerobic exercise has been shown to decrease the amount of oxidative stress within the ovaries, and in humans, chronic aerobic exercise has been shown to increase antioxidant production systemically. This hypothesis should be tested in both a mouse model, using sedentary and exercising mice treated with chemotherapy drugs that commonly result in CIA, as well as a human model to determine the effects of low to moderate intensity aerobic exercise on ovarian function in premenopausal women undergoing chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: Design and rationale of a randomized controlled trial (BEATE study)
- Author
-
Schmidt, Martina E., Wiskemann, Joachim, Krakowski-Roosen, Holger, Knicker, Axel J., Habermann, Nina, Schneeweiss, Andreas, Ulrich, Cornelia M., and Steindorf, Karen
- Subjects
- *
RANDOMIZED controlled trials , *BREAST cancer patients , *RELAXATION for health , *ADJUVANT treatment of cancer , *CANCER chemotherapy , *FATIGUE prevention , *RESISTANCE training , *CARDIOPULMONARY system - Abstract
Abstract: Background and rationale: Cancer-related fatigue is a common severe symptom in breast cancer patients, especially during chemotherapy. Exercise appears to be promising in prevention or treatment of fatigue. Resistance training as an accompanying treatment to chemotherapy has been minimally investigated, yet might counteract muscle degradation and inflammation caused by many chemotherapeutics, and thus forestall or reduce fatigue. Previous exercise trials mostly compared the intervention with ‘usual care’. Therefore, it is unclear to what extent the observed effects on fatigue are based on physical adaptations by exercise itself, or rather on psycho-social factors linked to the group support or attention by the trainer. Methods and design: The BEATE study is a randomized, controlled intervention trial comparing a 12-week supervised progressive resistance training program with a supervised group-based progressive muscle relaxation training in 100 patients with breast cancer under adjuvant chemotherapy. The primary endpoint is cancer-related fatigue; secondary endpoints include quality of life, depression, and cognitive capacity. In addition, isokinetic and isometric muscle strength, cardiorespiratory fitness, and body composition are measured, and biomarkers, such as inflammatory parameters, cortisol, and oxidative stress are analyzed in blood, saliva and urine. Safety of the resistance training during chemotherapy is monitored. Discussion: Strengths of the BEATE study include the investigation of progressive resistance training parallel with chemotherapy, the choice of a control group that enables an evaluation of the physiological effects of exercise beyond potential psycho-social effects, and the comprehensive and high-quality assessment of physiological factors and biomarkers potentially related to fatigue. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
10. Out of balance - Postural control in cancer patients before and after neurotoxic chemotherapy.
- Author
-
Müller, Jana, Ringhof, Steffen, Vollmer, Maxmilian, Jäger, Laura Bettina, Stein, Thorsten, Weiler, Markus, and Wiskemann, Joachim
- Subjects
- *
POSTURE , *CANCER patients , *CANCER chemotherapy , *GAIT in humans , *RANK correlation (Statistics) , *NEUROTOXICOLOGY , *RESEARCH , *FERRANS & Powers Quality of Life Index , *PROPRIOCEPTION , *SYNDROMES , *PERIPHERAL neuropathy , *POSTURAL balance , *RESEARCH methodology , *ANTINEOPLASTIC agents , *CASE-control method , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *QUALITY of life , *ACCIDENTAL falls , *TUMORS , *LONGITUDINAL method - Abstract
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side effect deriving from neurotoxic chemotherapeutic agents. The underlying nerve injury can affect proprioception causing impaired postural control, gait difficulties and a higher risk of falling. Overall, the symptoms and functional limitations negatively affect patients' independence and quality of life.Research Question: Our objective was to analyze postural control in cancer patients before and after neurotoxic chemotherapy and to compare these data to healthy controls.Methods: Participants were 35 cancer patients (PAT) and 35 healthy, one-to-one gender, age, height, and weight matched controls (HMC). Postural control of HMC was tested once, whereas PAT were tested prior to (PATpre) and three weeks after completion of neurotoxic chemotherapy (PATpost). Temporal, spatial and frequency domain measures of the center of pressure (COP) were calculated using a force plate. The following balance conditions were analyzed: bipedal stance with open (BPEO) and closed eyes (BPEC), semi-tandem (STEO, STEC) and monopedal stance (MPEO). CIPN was assessed clinically (Total Neuropathy Score) and via questionnaire. Time and group differences were determined by using Wilcoxon-signed-rank tests. Spearman correlation was applied to analyze associations between severity of CIPN and postural control.Results: PATpost showed significantly increased temporal and spatial measures of the COP (p < .05) - both after neurotoxic chemotherapy (PATpre-PATpost) and in comparison to HMC. Withdrawal of visual control resulted in greater temporal and spatial COP displacements in PATpost than in the comparative groups (PATpre, HMC). Correlation analyzes revealed moderate associations of COP measures with clinical CIPN measures and low to none for the questionnaires.Significance: Three weeks after completion of neurotoxic chemotherapy, PATpost showed significant balance deficits compared to PATpre and HMC. Especially the deficits in the standing conditions with closed eyes may indicate an impaired proprioception. This hypothesis is supported by the finding that stronger CIPN symptoms were associated with poorer postural control. However, future studies need to take further influencing factors on postural control into account (e.g. strength) in order to generate efficacious rehabilitation measures. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
11. Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial.
- Author
-
Schmidt, Martina E., Meynköhn, Anna, Habermann, Nina, Wiskemann, Joachim, Oelmann, Jan, Hof, Holger, Wessels, Sabine, Klassen, Oliver, Debus, Jürgen, Potthoff, Karin, Steindorf, Karen, and Ulrich, Cornelia M.
- Subjects
- *
INFLAMMATION , *BREAST cancer patients , *BREAST cancer treatment , *ADJUVANT treatment of cancer , *CANCER radiotherapy , *RANDOMIZED controlled trials , *THERAPEUTICS , *PAIN management , *ANALYSIS of variance , *BREAST tumors , *CELL receptors , *COMPARATIVE studies , *MENTAL depression , *FATIGUE (Physiology) , *INTERLEUKINS , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *PAIN , *QUESTIONNAIRES , *RADIOTHERAPY , *RESEARCH , *EVALUATION research , *RESISTANCE training - Abstract
Purpose: To explore the mediating role of inflammatory parameters in the development of fatigue, pain, and potentially related depressive symptoms during radiation therapy for breast cancer and its mitigation by resistance exercise.Methods and Materials: Breast cancer patients scheduled for adjuvant radiation therapy were randomized to 12-week progressive resistance exercise training (EX) or a relaxation control group. Interleukin-6 (IL-6) and interleukin-1 receptor antagonist (IL-1ra) were measured in serum samples collected before, at the end, and 6 weeks after radiation therapy from 103 chemotherapy-naïve participants. Fatigue was assessed with the multidimensional Fatigue Assessment Questionnaire, pain with the European Organization for Research and Treatment of Cancer QLQ-C30, and depressive symptoms with the Center for Epidemiologic Studies Depression Scale. Analysis of covariance models, partial correlations, Freedman-Schatzkin tests, and R(2) effect-size measures for mediation were calculated.Results: The analysis of covariance models revealed a significant intervention effect on IL-6 (P=.010) and the IL-6/IL-1ra ratio (P=.018), characterized by a marked increase during radiation therapy among controls, but no significant change in EX. Interleukin-1 receptor antagonist did not change significantly in either group (P=.88). Increased IL-6 and IL-6/IL-1ra levels at the end of radiation therapy were significantly associated with increased physical fatigue and pain 6 weeks after radiation. We observed significant partial mediation by IL-6 and IL-6/IL-1ra of the effect of resistance exercise on physical fatigue (Freedman-Schatzkin P=.023 and P<.001) and pain (both P<.001). Hereby IL-6 and IL-6/IL-1ra mediated between 15% and 24% of the variance of physical fatigue and pain explained by the intervention.Conclusions: This randomized, controlled trial showed a significantly increased proinflammatory cytokine level after adjuvant radiation therapy in breast cancer patients. This effect was counteracted by progressive resistance exercise training. Interleukin-6 and the IL-6/IL-1ra ratio seemed to mediate the beneficial effect of exercise on physical fatigue and pain but only to a small extent. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.